How to Choose Home Monitoring Equipment for Remote Patient Monitoring

What practice administrators, ACO procurement leads, and home health agencies need to know before buying connected RPM devices.

What this is and who buys it

Remote Patient Monitoring (RPM) refers to FDA-cleared connected devices — blood pressure cuffs, pulse oximeters, weight scales, glucometers, continuous glucose monitors (CGMs), ECG patches, and multiparameter hubs — that automatically transmit physiologic data from a patient's home to a clinician dashboard. The operative word is automatically: CMS reimbursement under CPT codes 99453 and 99454 requires that readings be captured and digitally transmitted without patient self-entry, a requirement that immediately narrows the eligible product field. The home-care segment of the global RPM device market was estimated at $18.1 billion in 2025 [S7], reflecting a decade of policy change, broadband expansion, and chronic-disease burden pushing monitoring outside hospital walls.

Buyers in this category are rarely individuals shopping for consumer health gadgets. They are typically practice administrators building chronic-care management (CCM) or RPM billing lines, ACO/CIN procurement leads standardizing devices across a patient population, home health agencies supplementing skilled nursing visits, and ASC discharge planners managing post-surgical or transitional care within the 30-day readmission window. The decision involves not just hardware specifications but connectivity architecture, platform contracts, EHR integration, staff workflows, and CMS billing mechanics — all simultaneously.

What makes this category unusual compared to conventional medical equipment procurement is that the device itself is often a loss leader. Revenue is generated through CMS CPT codes tied to days of data transmission and clinician time — meaning device compliance rates, not just clinical accuracy, directly determine program ROI.

Key decision factors

Connectivity architecture is the single most consequential hardware decision. Cellular-enabled devices (